Variables
|
Univariate analysis
|
Multivariate analysis
|
---|
OR (95% CI)
|
P value
|
Model 1
|
Model 2
|
Model 3
|
---|
OR (95% CI)
|
P value
|
OR (95% CI)
|
P value
|
OR (95% CI)
|
P value
|
---|
Clinical parameters
|
Age
|
1.07 (1.02–1.12)
|
< 0.01
|
1.06 (1.01–1.13)
|
0.03
|
1.07 (1.01–1.14)
|
0.03
|
1.08 (1.01–1.40)
|
0.02
|
Female
|
1.03 (0.46–2.29)
|
0.94
|
2.17 (0.79–6.02)
|
0.14
|
2.44 (0.85–7.03)
|
0.09
| | |
Heart failure
|
3.19 (1.33–7.62)
|
0.01
|
1.85 (0.63–5.45)
|
0.27
|
1.56 (0.48–5.24)
|
0.46
| | |
CHA2DS2-VASc score
|
1.41 (1.04–1.19)
|
0.03
|
1.04 (0.55–1.97)
|
0.91
|
1.14 (0.57–2.29)
|
0.71
|
1.07 (0.57–1.63)
|
0.71
|
LA parameters
|
LAEF
|
0.97 (0.94–0.99)
|
0.01
|
1.00 (0.96–1.04)
|
0.99
| | | | |
iLAVmax
|
1.02 (1.00–1.04)
|
0.03
|
0.99 (0.96–1.02)
|
0.53
| | |
0.99 (0.96–1.03)
|
0.81
|
LA GLS
|
0.91 (0.86–0.97)
|
< 0.01
|
0.99 (0.90–1.09)
|
0.88
|
0.99 (0.89–1.10)
|
0.77
|
0.99 (0.89–1.09)
|
0.78
|
LA MD
|
1.25 (1.22–1.39)
|
< 0.01
|
1.20 (1.07–1.36)
|
< 0.01
|
1.29 (1.11–1.49)
|
< 0.01
|
1.18 (1.03–1.34)
|
< 0.01
|
LAA parameters
|
LAAEV
|
0.18 (0.02–1.33)
|
0.09
| | |
16.81 (1.28–220.9)
|
0.03
|
4.83 (0.45–52.15)
|
0.05
|
LAAEF
|
0.98 (0.97–1.00)
|
0.13
| | |
1.01 (0.98–1.05)
|
0.45
| | |
LAA dense SEC/thrombus
|
3.93 (1.64–9.46)
|
< 0.01
| | |
4.39 (1.33–14.53)
|
0.02
|
3.63 (1.16–11.35)
|
0.03
|
LAA GLS
|
0.84 (0.75–0.94)
|
< 0.01
|
0.96 (0.85–1.09)
|
0.53
|
0.96 (0.84–1.10)
|
0.57
|
0.96 (0.84–1.09)
|
0.49
|
LAA MD
|
1.21 (1.09–1.32)
|
< 0.01
|
1.19 (1.07–1.33)
|
< 0.01
|
1.22 (1.08–1.38)
|
< 0.01
|
1.21 (1.08–1.36)
|
< 0.01
|
- AF atrial fibrillation, BMI body mass index, CI Confidence intervals, GLS global longitudinal strain, i indexed to body surface area, LA left atrium, LAA left atrial appendage, LAAEF LAA emptying fraction, LAAEV LAA emptying velocity, LAEF LA emptying fraction, MD mechanical dispersion, OR odds ratio, SEC spontaneous echo contrast, Vmax maximal volume